
Coronavirus Vaccines: Five Key Questions as Trials Begin
Some experts warn that accelerated testing will involve risky trade-offs

Coronavirus Vaccines: Five Key Questions as Trials Begin
Some experts warn that accelerated testing will involve risky trade-offs

How COVID-19 Drug Hunters Spot Virus-Fighting Compounds
A big project looks at “doorways” the coronavirus uses to get into cells—and finds drugs that could block them


Larry Brilliant Helped to Eradicate Smallpox—and He Has Advice for COVID-19
The doctor’s firsthand experience with epidemics gives him a unique view of our current health crisis

How to Triage Patients Who Need Intensive Care
A new computer model analyzes when to admit people to intensive care units—and when to move them out—which could help doctors handle the coronavirus surge

How Does the Coronavirus Test Work? 5 Questions Answered
A molecular biologist explains how the kits function, and why the U.S. has faced problems

Researchers Rush to Test Coronavirus Vaccine in People
In a big break from protocol, scientists are not waiting to see how well it works in animals first

Synthetic Biologists Think They Can Develop a Better Coronavirus Vaccine Than Nature Could
The Bill and Melinda Gates Foundation and the National Institutes of Health are betting on a different approach than existing efforts for battling COVID-19

The Clitoris, Uncovered: An Intimate History
Female anatomy hasn’t changed, but our understanding of it sure has

The Clitoris: A Reveal Two Millennia in the Making
In the history of sexual anatomy, the clitoris has long been dismissed, demeaned and misunderstood. Here is a view of the clitoris you’ve probably never seen.

Is That Two-Week Course of Antibiotics Really Necessary?
Overuse of these drugs can be dangerous and contribute to bacterial resistance

The Married Researchers Racing to Stop Prion Disease
For Sonia Minikel Vallabh and Eric Vallabh Minikel, the quest to prevent a fatal neurodegenerative disease is personal

A Breakthrough in Genetic Medicine for Rare Diseases
A long-disdained therapy that targets RNA is suddenly achieving spectacular success